{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:45:17Z","timestamp":1786985117203,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioadv.2024.213853","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T03:09:20Z","timestamp":1713236960000},"page":"213853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients"],"prefix":"10.1016","volume":"160","author":[{"given":"Raghuraj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eupa","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agrim","family":"Jhilta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2024.213853_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.55563\/clinexprheumatol\/l9lyen","article-title":"Pathogenesis of rheumatoid arthritis: one year in review 2022","volume":"40","author":"Petrelli","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bioadv.2024.213853_bb0010","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis, nature reviews","volume":"18","author":"Finckh","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioadv.2024.213853_bb0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bioadv.2024.213853_bb0020","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bioadv.2024.213853_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Research"},{"key":"10.1016\/j.bioadv.2024.213853_bb0030","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2217\/nnm.15.45","article-title":"Nanomedicine delivers promising treatments for rheumatoid arthritis","volume":"10","author":"Prasad","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2024.213853_bb0035","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2146\/ajhp050514","article-title":"Treatment of rheumatoid arthritis","volume":"63","author":"Gaffo","year":"2006","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.bioadv.2024.213853_bb0040","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/1381612829666230406102935","article-title":"New generation smart drug delivery Systems for Rheumatoid Arthritis","volume":"29","author":"Singh","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioadv.2024.213853_bb0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5001\/omj.2011.101","article-title":"Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs","volume":"26","author":"Al-Saeed","year":"2011","journal-title":"Oman Med. J."},{"key":"10.1016\/j.bioadv.2024.213853_bb0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-2600(18)30058-4","article-title":"Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study","volume":"6","author":"Hawcutt","year":"2018","journal-title":"The Lancet Respir. Med."},{"key":"10.1016\/j.bioadv.2024.213853_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/187152811304140915152102","article-title":"An update on disease modifying antirheumatic drugs","volume":"13","author":"Joshi","year":"2014","journal-title":"Inflammation & Allergy-Drug Targets"},{"key":"10.1016\/j.bioadv.2024.213853_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.actbio.2019.03.010","article-title":"Intra-articular targeting of nanomaterials for the treatment of osteoarthritis","volume":"93","author":"Brown","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2024.213853_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/1941738109350438","article-title":"The basic science of articular cartilage: structure, composition, and function","volume":"1","author":"Sophia Fox","year":"2009","journal-title":"Sports Health"},{"key":"10.1016\/j.bioadv.2024.213853_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/BOR.0000000000000761","article-title":"Recent advances in targeted drug delivery for treatment of osteoarthritis","volume":"33","author":"Mehta","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bioadv.2024.213853_bb0075","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.apsb.2021.03.013","article-title":"Nanomedicines for the treatment of rheumatoid arthritis: state of art and potential therapeutic strategies","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioadv.2024.213853_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8900658","article-title":"The therapeutic potential of targeted Nanoparticulate systems to treat rheumatoid arthritis","volume":"2022","author":"Liang","year":"2022","journal-title":"Journal of Nanomaterials"},{"key":"10.1016\/j.bioadv.2024.213853_bb0085","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1039\/D1RA00328C","article-title":"Application of nanomaterials in the treatment of rheumatoid arthritis","volume":"11","author":"Zheng","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2024.213853_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jconrel.2022.05.054","article-title":"Polymer nanotherapeutics: a versatile platform for effective rheumatoid arthritis therapy","volume":"348","author":"Nooreen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2024.213853_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4146","article-title":"The role of the circadian clock in rheumatoid arthritis","volume":"15","author":"Gibbs","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bioadv.2024.213853_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/282495","article-title":"Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis","volume":"2014","author":"Yoshida","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bioadv.2024.213853_bb0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Frontiers in Bioscience-Landmark"},{"key":"10.1016\/j.bioadv.2024.213853_bb0110","first-page":"197","article-title":"Matrix metalloproteinase 9 (MMP-9) in patients with rheumatoid arthritis","volume":"7","author":"Seki","year":"1997","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bioadv.2024.213853_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112027","article-title":"Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-a for site-specific and controlled drug delivery for cancer therapy","volume":"123","author":"Vaghasiya","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2024.213853_bb0120","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1021\/mp300320d","article-title":"Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B","volume":"9","author":"Jain","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2024.213853_bb0125","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1021\/bm800377w","article-title":"Synthesis and optimization of gelatin nanoparticles using the miniemulsion process","volume":"9","author":"Ethirajan","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioadv.2024.213853_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121805","article-title":"Crafting \u0263-L-Glutamyl-l-cysteine layered human serum albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia\/reperfusion injury via \u201c3A approach\u201d","volume":"289","author":"Fatima","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2024.213853_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120428","article-title":"Intranasal delivery of naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose","volume":"599","author":"Hasan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2024.213853_bb0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.micromeso.2016.08.009","article-title":"Inhalable microspheres with hierarchical pore size for tuning the release of biotherapeutics in lungs","volume":"235","author":"Sharma","year":"2016","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.bioadv.2024.213853_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2020.05.013","article-title":"Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis","volume":"324","author":"Sharma","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2024.213853_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213594","article-title":"Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation","volume":"154","author":"Jadhav","year":"2023","journal-title":"Biomaterials Advances"},{"key":"10.1016\/j.bioadv.2024.213853_bb0155","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1021\/acsabm.0c00497","article-title":"Matrix metalloproteinase-responsive mesoporous silica nanoparticles cloaked with cleavable protein for \u201cself-actuating\u201d on-demand controlled drug delivery for cancer therapy","volume":"3","author":"Vaghasiya","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioadv.2024.213853_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.powtec.2020.08.040","article-title":"Design and evaluation of inhalable nanocrystals embedded microparticles with enhanced redispersibility and bioavailability for breviscapine","volume":"377","author":"Chen","year":"2021","journal-title":"Powder Technol."},{"key":"10.1016\/j.bioadv.2024.213853_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.942417","article-title":"The synovial fluid fibroblast-like synoviocyte: a long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis","volume":"13","author":"Mahmoud","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2024.213853_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122585","article-title":"Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials","volume":"634","author":"Jakhar","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2024.213853_bb0175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s11547-019-01001-3","article-title":"Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis","volume":"124","author":"Salaffi","year":"2019","journal-title":"Radiol. Med."},{"key":"10.1016\/j.bioadv.2024.213853_bb0180","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1021\/acsabm.0c00242","article-title":"Matrix metalloproteinase-responsive PEGylated lipid nanoparticles for controlled drug delivery in the treatment of rheumatoid arthritis","volume":"3","author":"He","year":"2020","journal-title":"ACS Applied Bio Materials"},{"key":"10.1016\/j.bioadv.2024.213853_bb0185","article-title":"Exacerbation of symptomatic arthritis by cigarette smoke in experimental arthritis","volume":"15","author":"Kang","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.bioadv.2024.213853_bb0190","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jconrel.2021.07.005","article-title":"Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment","volume":"336","author":"Du","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2024.213853_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtchem.2021.100474","article-title":"Gelatin-coated gold nanoparticles as an effective pH-sensitive methotrexate drug delivery system for breast cancer treatment","volume":"20","author":"Khodashenas","year":"2021","journal-title":"Materials Today Chemistry"},{"key":"10.1016\/j.bioadv.2024.213853_bb0200","first-page":"162","article-title":"Optimization and evaluation of ketoconazole loaded nanostructured lipid carriers employing microwave-assisted technique","volume":"84","author":"Bhatia","year":"2022","journal-title":"Indian J. Pharm. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.bioadv.2024.213853_bb0205","article-title":"The role of interleukin-1 in the pathogenesis of rheumatoid arthritis","volume":"43","author":"Kay","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bioadv.2024.213853_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1725-6","article-title":"Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review","volume":"20","author":"Davignon","year":"2018","journal-title":"Arthritis Research Therapy"},{"key":"10.1016\/j.bioadv.2024.213853_bb0215","article-title":"Interleukin 6 and rheumatoid arthritis","volume":"2014","author":"Yoshida","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2024.213853_bb0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","article-title":"The role of TNF-\u03b1 in rheumatoid arthritis: a focus on regulatory T cells","volume":"2","author":"Farrugia","year":"2016","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.bioadv.2024.213853_bb0225","doi-asserted-by":"crossref","first-page":"070","DOI":"10.23937\/2469-5726\/1510070","article-title":"Severe MTX toxicity in rheumatic diseases\u2013analysis of 22 cases","volume":"5","author":"Bergner","year":"2019","journal-title":"J Rheum Dis Treat"},{"key":"10.1016\/j.bioadv.2024.213853_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8900658","article-title":"The therapeutic potential of targeted Nanoparticulate systems to treat rheumatoid arthritis","volume":"2022","author":"Liang","year":"2022","journal-title":"J. Nanomater."},{"key":"10.1016\/j.bioadv.2024.213853_bb0235","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1021\/la000614h","article-title":"Hydrophobically modified gelatin and its interaction in aqueous solution with sodium dodecyl sulfate","volume":"17","author":"Griffiths","year":"2001","journal-title":"Langmuir"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950824000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950824000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T13:00:32Z","timestamp":1738501232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950824000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"alternative-id":["S2772950824000967"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.213853","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2024.213853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213853"}}